The Critical Roles of Polysaccharides in Gut Microbial Ecology and Physiology

Annual Review of Microbiology

Volumn 71, Issue , 2017, Pages 349-369

  Porter, Nathan T ^a   Martens, Eric C ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Capsules; Carbohydrate digestion; Glycans; Microbiome; Microbiota; Polysaccharides

Indexed keywords

GLYCAN; GLYCOCONJUGATE; MICROBIALLY PRODUCED GLYCAN; POLYSACCHARIDE; UNCLASSIFIED DRUG;

BACTERIOPHAGE; BIOLOGICAL ACTIVITY; CARBOHYDRATE METABOLISM; DIGESTIVE FUNCTION; GENETIC VARIABILITY; GLYCOSYLATION; HUMAN; IMMUNE SYSTEM; INTESTINE FLORA; MICROBIAL COLONIZATION; PRIORITY JOURNAL; REVIEW; SYMBIONT; SYMBIOSIS; BACTERIUM; GROWTH, DEVELOPMENT AND AGING; METABOLISM; MICROFLORA;

BACTERIA; GASTROINTESTINAL MICROBIOME; HUMANS; METABOLIC NETWORKS AND PATHWAYS; MICROBIOTA; POLYSACCHARIDES; SYMBIOSIS;

EID: 85029284516     PISSN: 00664227     EISSN: 15453251     Source Type: Book Series    
DOI: 10.1146/annurev-micro-102215-095316     Document Type: Review

References (138)

1. Ainsworth S, Sadovskaya I, Vinogradov E, Courtin P, Guerardel Y, et al. 2014. Differences in lactococcal cell wall polysaccharide structure are major determining factors in bacteriophage sensitivity. mBio 5(3):e00880-14
2. Arana DM, Prieto D, Roman E, Nombela C, Alonso-Monge R, Pla J. 2009. The role of the cell wall in fungal pathogenesis. Microb. Biotechnol. 2(3):308-20
3. Avci FY, Kasper DL. 2010. How bacterial carbohydrates influence the adaptive immune system. Annu. Rev. Immunol. 28(1):107-30
4. AxelssonMA, Asker N, Hansson GC. 1998. O-glycosylated MUC2 monomer and dimer from LS 174T cells are water-soluble, whereas largerMUC2 species formed early during biosynthesis are insoluble and contain nonreducible intermolecular bonds. J. Biol. Chem. 273(30):18864-70
5. Bagenholm V, Reddy SK, Bouraoui H, Morrill J, Kulcinskaja E, et al. 2017. Galactomannan catabolism conferred by a polysaccharide utilization locus of Bacteroides ovatus: enzyme synergy and crystal structure of a ?-mannanase. J. Biol. Chem. 292:229-43
6. Barr JJ, Auro R, Furlan M, Whiteson KL, Erb ML, et al. 2013. Bacteriophage adhering tomucus provide a non-host-derived immunity. PNAS 110(26):10771-76
7. Barr JJ, YouleM, Rohwer F. 2013. Innate and acquired bacteriophage-mediated immunity. Bacteriophage 3(3):e25857
8. Bayer ME, Thurow H, Bayer MH. 1979. Penetration of the polysaccharide capsule of Escherichia coli (Bi161/42) by bacteriophage K29. Virology 94(1):95-118
9. Bello FD, Walter J, Hertel C, Hammes WP. 2001. In vitro study of prebiotic properties of levan-type exopolysaccharides from lactobacilli and non-digestible carbohydrates using denaturing gradient gel electrophoresis. Syst. Appl. Microbiol. 24(2):232-37
10. Ben David Y, Dassa B, Borovok I, Lamed R, Koropatkin NM, et al. 2015. Ruminococcal cellulosome systems from rumen to human. Env. Microbiol. 17(9):3407-26
11. Benjdia A, Martens EC, Gordon JI, Berteau O. 2011. Sulfatases and a radical S-adenosyl-L-methionine (AdoMet) enzyme are key for mucosal foraging and fitness of the prominent human gut symbiont, Bacteroides thetaiotaomicron. J. Biol. Chem. 286(29):25973-82
12. Berger B, Pridmore RD, Barretto C, Delmas-Julien F, Schreiber K, et al. 2007. Similarity and differences in the Lactobacillus acidophilus group identified by polyphasic analysis and comparative genomics. J. Bacteriol. 189(4):1311-21
13. Bergstrom K, Fu J, Johansson ME, Liu X, Gao N, et al. 2017. Core 1-and 3-derived O-glycans collectively maintain the colonic mucus barrier and protect against spontaneous colitis in mice. Mucosal Immunol. 10:91-103
14. Bertozzi CR, RabukaD. 2009. Structural basis of glycan diversity. In Essentials of Glycobiology, ed. A Varki, RD Cummings, J Esko, pp. 23-36. New York: Cold Spring Harb. Press. 2nd ed.
15. Bjursell MK,Martens EC,Gordon JI. 2006. Functional genomic and metabolic studies of the adaptations of a prominent adult human gut symbiont, Bacteroides thetaiotaomicron, to the suckling period. J. Biol. Chem. 281(47):36269-79
16. Booth SJ, Van Tassell RL, Johnson JL, Wilkins TD. 1979. Bacteriophages of Bacteroides. Rev. Infect. Dis. 1(2):325-36
17. Bry L, Falk PG, Midtvedt T, Gordon JI. 1996. A model of host-microbial interactions in an open mammalian ecosystem. Science 273(5280):1380-83
18. Burt S, Meldrum S, Woods DR, Jones DT. 1978. Colonial variation, capsule formation, and bacteriophage resistance in Bacteroides thetaiotaomicron. Appl. Environ. Microbiol. 35(2):439-43
19. Caffall KH,Mohnen D. 2009. The structure, function, and biosynthesis of plant cell wall pectic polysaccharides. Carbohydr. Res. 344(14):1879-1900
20. Cameron EA, Sperandio V. 2015. Frenemies: signaling and nutritional integration in pathogenmicrobiota-host interactions. Cell Host Microbe 18(3):275-84
21. Chatzidaki-Livanis M, Coyne MJ, Comstock LE. 2009. A family of transcriptional antitermination factors necessary for synthesis of the capsular polysaccharides of Bacteroides fragilis. J. Bacteriol. 191(23):7288-95
22. Chatzidaki-Livanis M, Weinacht KG, Comstock LE. 2010. Trans locus inhibitors limit concomitant polysaccharide synthesis in the human gut symbiont Bacteroides fragilis. PNAS 107(26):11976-80
23. Chen XY,Woodward A, ZijlstraRT,GänzleaMG. 2014. Exopolysaccharides synthesized by Lactobacillus reuteri protect against enterotoxigenic Escherichia coli in piglets. Appl. Environ. Microbiol. 80(18):5752-60
24. Cimermancic P, Medema MH, Claesen J, Kurita K, Wieland Brown LC, et al. 2014. Insights into secondary metabolism from a global analysis of prokaryotic biosynthetic gene clusters. Cell 158(2):412-21
25. Cockburn DW, Koropatkin NM. 2016. Polysaccharide degradation by the intestinal microbiota and its influence on human health and disease. J. Mol. Biol. 428(16):3230-52
26. Cockburn DW, Orlovsky NI, Foley MH, Kwiatkowski KJ, Bahr CM, et al. 2015. Molecular details of a starch utilization pathway in the human gut symbiont Eubacterium rectale. Mol. Microbiol. 95(2):209-30
27. Coyne MJ, Chatzidaki-Livanis M, Paoletti LC, Comstock LE. 2008. Role of glycan synthesis in colonization of the mammalian gut by the bacterial symbiont Bacteroides fragilis. PNAS 105(35):13099-104
28. Coyne MJ, Comstock LE. 2008. Niche-specific features of the intestinal Bacteroidales. J. Bacteriol. 190(2):736-42
29. Coyne MJ, Tzianabos AO, Mallory BC, Carey VJ, Kasper DL, Comstock LE. 2001. Polysaccharide biosynthesis locus required for virulence of Bacteroides fragilis. Infect. Immun. 69(7):4342-50
30. Coyne MJ, Weinacht KG, Krinos CM, Comstock LE. 2003. Mpi recombinase globally modulates the surface architecture of a human commensal bacterium. PNAS 100(18):10446-51
31. Cuskin F, Lowe EC, Temple MJ, Zhu Y, Cameron EA, et al. 2015. Human gut Bacteroidetes can utilize yeast mannan through a selfish mechanism. Nature. 517(7533):165-69.
32. De Palencia PF, Werning ML, Sierra-Filardi E, Dueñas MT, Irastorza A, et al. 2009. Probiotic properties of the 2-substituted (1,3)-?-D-glucan-producing bacterium Pediococcus parvulus 2.6. Appl. Environ. Microbiol. 75(14):4887-91
33. Denou E, Pridmore RD, Berger B, Panoff JM, Arigoni F, Brüssow H. 2008. Identification of genes associated with the long-gut-persistence phenotype of the probiotic Lactobacillus johnsonii strain NCC533 using a combination of genomics and transcriptome analysis. J. Bacteriol. 190(9):3161-68
34. Dertli E, Colquhoun IJ, Gunning AP, Bongaerts RJ, Le Gall G, et al. 2013. Structure and biosynthesis of two exopolysaccharides produced by Lactobacillus johnsonii FI9785. J. Biol. Chem. 288(44):31938-51
35. DesaiMS, Seekatz AM, KoropatkinNM, KamadaN,Hickey CA, et al. 2016. A dietary fiber-deprived gut microbiota degrades the colonic mucus barrier and enhances pathogen susceptibility. Cell 167(5):1339-1353.e21
36. Despres J, Forano E, Lepercq P, Comtet-Marre S, Jubelin G, et al. 2016. Unraveling the pectinolytic function of Bacteroides xylanisolvens using a RNA-seq approach and mutagenesis. BMC Genom. 17:147
37. Despres J, Forano E, Lepercq P, Comtet-Marre S, Jubelin G, et al. 2016. Xylan degradation by the human gut Bacteroides xylanisolvens XB1AT involves two distinct gene clusters that are linked at the transcriptional level. BMC Genom. 17:326
38. DoniaMS, Cimermancic P, Schulze CJ,Wieland Brown LC,Martin J, et al. 2014. A systematic analysis of biosynthetic gene clusters in the human microbiome reveals a common family of antibiotics. Cell 158(6):1402-14
39. Earle KAA, Billings G, Sigal M, Lichtman JSS, Hansson GCC, et al. 2015. Quantitative imaging of gut microbiota spatial organization. Cell Host Microbe 18(4):478-88
40. Ejby M, Fredslund F, Andersen JM, Vujic?ićZ? agar A, Henriksen JR, et al. 2016. An ATP binding cassette transporter mediates the uptake of ?-(1,6)-linked dietary oligosaccharides in Bifidobacterium and correlates with competitive growth on these substrates. J. Biol. Chem. 291(38):20220-31
41. Ejby M, Fredslund F, Vujicic-Zagar A, Svensson B, Slotboom DJ, Abou Hachem M. 2013. Structural basis for arabinoxylo-oligosaccharide capture by the probiotic Bifidobacterium animalis subsp. lactis Bl-04. Mol. Microbiol. 90(5):1100-12
42. El Kaoutari A, Armougom F, Gordon JI, Raoult D, Henrissat B. 2013. The abundance and variety of carbohydrate-active enzymes in the human gut microbiota. Nat. Rev. Microbiol. 11(7):497-504
43. Engevik MA, Aihara E, Montrose MH, Shull GE, Hassett DJ, Worrell RT. 2013. Loss of NHE3 alters gutmicrobiota composition and influences Bacteroides thetaiotaomicron growth. Am. J. Physiol.Gastrointest. Liver Physiol. 305(10):G697-711
44. Fanning S, Hall LJ, Cronin M, Zomer A, MacSharry J, et al. 2012. Bifidobacterial surfaceexopolysaccharide facilitates commensal-host interaction through immune modulation and pathogen protection. PNAS 109(6):2108-13
45. Ferrario C, Milani C, Mancabelli L, Lugli GA, Duranti S, et al. 2016. Modulation of the eps-ome transcription of bifidobacteria through simulation of human intestinal environment. FEMS Microbiol. Ecol. 92(4):1-12
46. Ferreyra JA, Wu KJ, Hryckowian AJ, Bouley DM,Weimer BC, Sonnenburg JL. 2014. Gut microbiotaproduced succinate promotes C. difficile infection after antibiotic treatment or motility disturbance. Cell Host Microbe. 16(6):770-77
47. Flint HJ, Scott KP, Duncan SH, Louis P, Forano E. 2012. Microbial degradation of complex carbohydrates in the gut. Gut Microbes 3(4):289-306
48. Foley MH, Cockburn DW, Koropatkin NM. 2016. The Sus operon: a model system for starch uptake by the human gut Bacteroidetes. Cell. Mol. Life Sci. 73(14):2603-17
49. Fu J, Wei B, Wen T, Johansson MEV, Liu X, et al. 2011. Loss of intestinal core 1-derived O-glycans causes spontaneous colitis in mice. J. Clin. Investig. 121(4):1657-66
50. Garrido D, Kim JH, German JB, RaybouldHE, Mills DA. 2011. Oligosaccharide binding proteins from Bifidobacterium longum subsp. infantis reveal a preference for host glycans. PLOS ONE 6(3):e17315
51. Gupta DS, Jann B, Schmidt G, Golecki JR, Orskov I, et al. 1982. Coliphage K5, specific for E. coli exhibiting the capsular K5 antigen. FEMS Microbiol. Lett. 14:75-78
52. Hehemann J-H, Boraston AB, CzjzekM. 2014.Asweet newwave: Structures andmechanisms of enzymes that digest polysaccharides from marine algae. Curr. Opin. Struct. Biol. 28:77-86
53. Hehemann J-H, Correc G, Barbeyron T, Helbert W, Czjzek M, Michel G. 2010. Transfer of carbohydrate-active enzymes from marine bacteria to Japanese gutmicrobiota. Nature 464(7290):908-12
54. Hehemann J-H, Kelly AG, Pudlo NA, Martens EC, Boraston AB. 2012. Bacteria of the human gut microbiome catabolize red seaweed glycans with carbohydrate-active enzyme updates from extrinsic microbes. PNAS 109(48):19786-91
55. Holmén Larsson JM, Thomsson KA, Rodŕ?guez-Pi ñeiro AM, Karlsson H, Hansson GC. 2013. Studies of mucus in mouse stomach, small intestine, and colon: III. Gastrointestinal Muc5ac and Muc2 mucin O-glycan patterns reveal a regiospecific distribution. Am. J. Physiol. Gastrointest. Liver Physiol. 305(5):G357-63
56. HooperLV, Xu J, Falk PG,MidtvedtT,Gordon JI. 1999.Amolecular sensor that allows a gut commensal to control its nutrient foundation in a competitive ecosystem. PNAS 96(17):9833-38
57. Hoskins LC, Boulding ET. 1981. Mucin degradation in human colon ecosystems: evidence for the existence and role of bacterial subpopulations producing glycosidases as extracellular enzymes. J. Clin. Investig. 67(1):163-72
58. JohanssonME, Sjovall H, Hansson GC. 2013. The gastrointestinal mucus system in health and disease. Nat. Rev. Gastroenterol. Hepatol. 10(6):352-61
59. Johansson MEV, Phillipson M, Petersson J, Velcich A, Holm L, Hansson GC. 2008. The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria. PNAS 105(39):15064-69
60. Jones SE, Knight KL. 2012. Bacillus subtilis-mediated protection from Citrobacter rodentium-associated enteric disease requires espH and functional flagella. Infect. Immun. 80(2):710-19
61. Jones SE, Paynich ML, Kearns DB, Knight KL. 2014. Protection from intestinal inflammation by bacterial exopolysaccharides. J. Immunol. 192(10):4813-20
62. Kashyap PC, Marcobal A, Ursell LK, Smits SA, Sonnenburg ED, et al. 2013. Genetically dictated change in host mucus carbohydrate landscape exerts a diet-dependent effect on the gut microbiota. PNAS 110(42):17059-64
63. KellerR,Traub N. 1974. The characterization of Bacteroides fragilis bacteriophage recovered from animal sera: observations on the nature of Bacteroides phage carrier cultures. J. Gen. Virol. 24(1):179-89
64. Kelly RJ, Rouquier S, Giorgi D, Lennon GG, Lowe JB. 1995. Sequence and expression of a candidate for the human Secretor blood group ?(1,2)fucosyltransferase gene (FUT2): Homozygosity for an enzymeinactivating nonsense mutation commonly correlates with the non-secretor phenotype. J. Biol. Chem. 270:4640-49
65. KudelkaMR, Hinrichs BH, Darby T,Moreno CS, Nishio H, et al. 2016. Cosmc is an X-linked inflammatory bowel disease risk gene that spatially regulates gut microbiota and contributes to sex-specific risk. PNAS 113(51):14787-92
66. Larsbrink J, Rogers TE, Hemsworth GR, McKee LS, Tauzin AS, et al. 2014. A discrete genetic locus confers xyloglucan metabolism in select human gut Bacteroidetes. Nature 506:498-502
67. Lebeer S, Claes IJJ, Verhoeven TLA, Vanderleyden J, De Keersmaecker SCJ. 2011. Exopolysaccharides of Lactobacillus rhamnosus GG form a protective shield against innate immune factors in the intestine. Microb. Biotechnol. 4(3):368-74
68. Leiman PG, Battisti AJ, Bowman VD, Stummeyer K, Mühlenhoff M, et al. 2007. The structures of bacteriophages K1E and K1-5 explain processive degradation of polysaccharide capsules and evolution of new host specificities. J. Mol. Biol. 371(3):836-49
69. Lindström C, Holst O,Nilsson L, Oste R, Andersson KE. 2012. Effects of Pediococcus parvulus 2.6 and its exopolysaccharide on plasma cholesterol levels and inflammatory markers in mice. AMB Express 2(1):66
70. Liu CH, Lee SM, Vanlare JM, Kasper DL, Mazmanian SK. 2008. Regulation of surface architecture by symbiotic bacteria mediates host colonization. PNAS 105(10):3951-56
71. Looijesteijn PJ,Trapet L,DeVries E, Abee T, Hugenholtz J. 2001. Physiological function of exopolysaccharides produced by Lactococcus lactis. Int. J. Food Microbiol. 64(1-2):71-80
72. Lynch J, Sonnenburg J. 2012. Prioritization of a plant polysaccharide over a mucus carbohydrate is enforced by a Bacteroides hybrid two-component system. Mol. Microbiol. 85(3):478-91
73. Martens EC, Chiang HC, Gordon JI. 2008. Mucosal glycan foraging enhances fitness and transmission of a saccharolytic human gut bacterial symbiont. Cell Host Microbe 4(5):447-57
74. Martens EC, Koropatkin NM, Smith TJ, Gordon JI. 2009. Complex glycan catabolism by the human gut microbiota: the Bacteroidetes Sus-like paradigm. J. Biol. Chem. 284(37):24673-77
75. Martens EC, Lowe EC, Chiang H, Pudlo NA, Wu M, et al. 2011. Recognition and degradation of plant cell wall polysaccharides by two human gut symbionts. PLOS Biol. 9(12):e1001221
76. Martens EC, Roth R, Heuser JE, Gordon JI. 2009. Coordinate regulation of glycan degradation and polysaccharide capsule biosynthesis by a prominent human gut symbiont. J. Biol. Chem. 284(27):18445-57
77. Mazmanian S, Liu C, Tzianabos A, Kasper D. 2005. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell 122(1):107-18
78. Mazmanian SK, Kasper DL. 2006. The love-hate relationship between bacterial polysaccharides and the host immune system. Nat. Rev. Immunol. 6(11):849-58
79. Mazmanian SK, Round JL, Kasper DL. 2008. A microbial symbiosis factor prevents intestinal inflammatory disease. Nature 453(7195):620-25
80. McGuckin MA, Linden SK, Sutton P, Florin TH. 2011. Mucin dynamics and enteric pathogens. Nat. Rev. Microbiol. 9(4):265-78
81. McNultyNP,WuM, Erickson AR, PanC,Erickson BK, et al. 2013. Effects of diet on resource utilization by amodel human gutmicrobiota containing Bacteroides cellulosilyticus WH2, a symbiontwith an extensive glycobiome. PLOS Biol. 11(8):e1001637
82. Molenaar D, Bringel F, Schuren FH, de Vos WM, Siezen RJ, Kleerebezem M. 2005. Exploring Lactobacillus plantarum genome diversity by using microarrays. J. Bacteriol. 187(17):6119-27
83. Morrill J, Kulcinskaja E, Sulewska AM, Lahtinen S, Stalbrand H, et al. 2015. The GH5 1,4-betamannanase from Bifidobacterium animalis subsp. lactis Bl-04 possesses a low-affinity mannan-binding module and highlights the diversity of mannanolytic enzymes. BMC Biochem. 16:26
84. Neff CP, Rhodes ME, Arnolds KL, Collins CB, Donnelly J, et al. 2016. Diverse intestinal bacteria contain putative zwitterionic capsular polysaccharides with anti-inflammatory properties. Cell Host Microbe 20:535-47
85. Ng KM, Ferreyra JA, Higginbottom SK, Lynch JB, Kashyap PC, et al. 2013. Microbiota-liberated host sugars facilitate post-antibiotic expansion of enteric pathogens. Nature 502(7469):96-99
86. Nimmich W, Schmidt G, Krallmann-Wenzel U. 1991. Two different Escherichia coli capsular polysaccharide depolymerases each associated with one of the coliphage ?K5 and ?K20. FEMS Microbiol. Lett. 82(2):137-41
87. Ochoa-Repáraz J, Mielcarz DW, Wang Y, Begum-Haque S, Dasgupta S, et al. 2010. A polysaccharide from the human commensal Bacteroides fragilis protects against CNS demyelinating disease. Mucosal Immunol. 3(5):487-95
88. Ogilvie LA, Jones BV. 2015. The human gut virome: a multifaceted majority. Front. Microbiol. 6:918
89. Onderdonk AB, Kasper DL, Cisneros RL, Bartlett JG. 1977. The capsular polysaccharide of Bacteroides fragilis as a virulence factor: Comparison of the pathogenic potential of encapsulated and unencapsulated strains. J. Infect. Dis. 136(1):82-89
90. Patrick S, Blakely GW, Houston S, Moore J, Abratt VR, et al. 2010. Twenty-eight divergent polysaccharide loci specifying within-and amongst-strain capsule diversity in three strains of Bacteroides fragilis. Microbiology 156(11):3255-69
91. Pauly M, Gille S, Liu LF, Mansoori N, de Souza A, et al. 2013. Hemicellulose biosynthesis. Planta 238(4):627-42
92. Pickard JM, Maurice CF, Kinnebrew MA, Abt MC, Schenten D, et al. 2014. Rapid fucosylation of intestinal epithelium sustains host-commensal symbiosis in sickness. Nature 514(7524):638-41
93. Png CW, Linden SK, Gilshenan KS, Zoetendal EG, McSweeney CS, et al. 2010. Mucolytic bacteria with increased prevalence in IBD mucosa augment in vitro utilization of mucin by other bacteria. Am. J. Gastroenterol. 105(11):2420-28
94. Pudlo NA, Urs K, Kumar SS, German JB, Mills DA, Martens EC. 2015. Symbiotic human gut bacteria with variable metabolic priorities for host mucosal glycans. mBio 6(6):e01282-15
95. Radke KL, Siegel EC. 1971. Mutation preventing capsular polysaccharide synthesis in Escherichia coli K-12 and its effect on bacteriophage resistance. J. Bacteriol. 106(2):432-37
96. Raftis EJ, Salvetti E, Torriani S, Felis GE, O'Toole PW. 2011. Genomic diversity of Lactobacillus salivarius. Appl. Environ. Microbiol. 77(3):954-65
97. Raghavan V,LoweEC,Townsend GE, BolamDN,Groisman EA. 2014. Tuning transcription of nutrient utilization genes to catabolic rate promotes growth in a gut bacterium. Mol. Microbiol. 93:1010-25
98. Rakoff-Nahoum S, CoyneMJ, Comstock LE. 2014. An ecological network of polysaccharide utilization among human intestinal symbionts. Curr. Biol. 24(1):40-49
99. Rakoff-Nahoum S, Foster KR, Comstock LE. 2016. The evolution of cooperation within the gut microbiota. Nature 533(7602):255-59
100. Reddy SK, Bagenholm V, Pudlo NA, Bouraoui H, Koropatkin NM, et al. 2016. A ?-mannan utilization locus in Bacteroides ovatus involves a GH36 ?-galactosidase active on galactomannans. FEBS Lett. 590(14):2106-18
101. Reyes A, Wu M, McNulty NP, Rohwer FL, Gordon JI. 2013. Gnotobiotic mouse model of phagebacterial host dynamics in the human gut. PNAS 110(50):20236-41
102. Roberts IS. 1996. The biochemistry and genetics of capsular polysaccharide production in bacteria. Annu. Rev. Microbiol. 50:285-315
103. Rogers TE, Pudlo NA, Koropatkin NM, Bell JSK, Moya Balasch M, et al. 2013. Dynamic responses of Bacteroides thetaiotaomicron during growth on glycan mixtures. Mol. Microbiol. 88:876-90
104. Rogowski A, Briggs JA, Mortimer JC, Tryfona T, Terrapon N, et al. 2015. Glycan complexity dictates microbial resource allocation in the large intestine. Nat. Commun. 6:7481.
105. Round JL, Lee SM, Li J, Tran G, Jabri B, et al. 2011. The Toll-like receptor 2 pathway establishes colonization by a commensal of the human microbiota. Science 332(6032):974-77
106. Ruas-Madiedo P, GueimondeM, Arigoni F, De Los Reyes-Gavilán CG,Margolles A. 2009. Bile affects the synthesis of exopolysaccharides by Bifidobacterium animalis. Appl. Environ. Microbiol. 75(4):1204-7
107. RuijssenaarsHJ, Stingele F, Hartmans S. 2000. Biodegradability of food-associated extracellular polysaccharides. Curr. Microbiol. 40(3):194-99
108. Salazar N, Gueimonde M, Hernández-Barranco AM, Ruas-Madiedo P, De Los Reyes-Gavilán CG. 2008. Exopolysaccharides produced by intestinal Bifidobacterium strains act as fermentable substrates for human intestinal bacteria. Appl. Environ. Microbiol. 74(15):4737-45
109. Salazar N, Ruas-Madiedo P, Kolida S, Collins M, Rastall R, et al. 2009. Exopolysaccharides produced by Bifidobacterium longum IPLA E44 and Bifidobacterium animalis subsp. lactis IPLA R1 modify the composition and metabolic activity of human faecal microbiota in pH-controlled batch cultures. Int. J. Food Microbiol. 135(3):260-67
110. Saxelin ML, Nurmiaho EL, Korhola MP, Sundman V. 1979. Partial characterization of a new C3-type capsule-dissolving phage of Streptococcus cremoris. Can. J. Microbiol. 25(10):1182-87
111. Schiavi E, GleinserM,Molloy E, Groeger D, Frei R, et al. 2016. The surface-associated exopolysaccharide of Bifidobacterium longum 35624 plays an essential role in dampening host proinflammatory responses and repressing local TH17 responses. Appl. Environ. Microbiol. 82(24):7185-96
112. Scholl D, Adhya S, Merril C. 2005. Escherichia coli K1's capsule is a barrier to bacteriophage T7. Appl. Environ. Microbiol. 71(8):4872-74
113. Scholl D, Rogers S, Adhya S,Merril CR. 2001. Bacteriophage K1-5 encodes two different tail fiber proteins, allowing it to infect and replicate on bothK1 andK5strains of Escherichia coli. J. Virol. 75(6):2509-15
114. SchwalmND,Townsend GE, Groisman EA. 2016. Multiple signals govern utilization of a polysaccharide in the gut bacterium Bacteroides thetaiotaomicron. mBio 7:e01342-16
115. Schwalm ND, Townsend GE, Groisman EA. 2017. Prioritization of polysaccharide utilization and control of regulator activation in Bacteroides thetaiotaomicron. Mol. Microbiol.104:32-45
116. Schwarzer D, Buettner FFR, Browning C, Nazarov S, Rabsch W, et al. 2012. A multivalent adsorption apparatus explains the broad host range of phage phi92: a comprehensive genomic and structural analysis. J. Virol. 86(19):10384-98
117. Sims IM, Frese SA, Walter J, Loach D, Wilson M, et al. 2011. Structure and functions of exopolysaccharide produced by gut commensal Lactobacillus reuteri 100-23. ISME J. 5(7):1115-24
118. Sonnenburg ED, Smits SA, Tikhonov M, Higginbottom SK, Wingreen NS, Sonnenburg JL. 2016. Diet-induced extinctions in the gut microbiota compound over generations. Nature 529(7585):212-15
119. Sonnenburg ED, Sonnenburg JL. 2014. Starving our microbial self: the deleterious consequences of a diet deficient in microbiota-accessible carbohydrates. Cell Metab. 20(5):779-86
120. Sonnenburg ED, Sonnenburg JL, Manchester JK, Hansen EE, Chiang HC, Gordon JI. 2006. A hybrid two-component system protein of a prominent human gut symbiont couples glycan sensing in vivo to carbohydrate metabolism. PNAS 103(23):8834-39
121. Sonnenburg JL, Xu J, Leip DD, Chen C-H, Westover BP, et al. 2005. Glycan foraging in vivo by an intestine-adapted bacterial symbiont. Science 307(5717):1955-59
122. Stanley P, Schacter H, Taniguchi N. 2009. N-glycans. In Essentials of Glycobiology, ed A Varki, RD Cummings, J Esko, pp. 101-14. New York: Cold Spring Harb. Press. 2nd ed.
123. Stummeyer K, Schwarzer D, Claus H, Vogel U, Gerardy-Schahn R, Mühlenhoff M. 2006. Evolution of bacteriophages infecting encapsulated bacteria: lessons from Escherichia coli K1-specific phages. Mol. Microbiol. 60(5):1123-35
124. Tailford LE, Crost EH, Kavanaugh D, Juge N. 2015. Mucin glycan foraging in the human gut microbiome. Front. Genet. 6:81
125. Thomas F, Barbeyron T, Tonon T, Genicot S, Czjzek M, Michel G. 2012. Characterization of the first alginolytic operons in a marine bacterium: from their emergence in marine Flavobacteriia to their independent transfers to marine Proteobacteria and human gut Bacteroides. Env. Microbiol. 14(9):2379-94
126. Tzianabos AO, Kasper DL, Cisneros RL, Smith RS, Onderdonk AB. 1995. Polysaccharide-mediated protection against abscess formation in experimental intra-abdominal sepsis. J. Clin. Investig. 96(6):2727-31
127. Tzianabos AO, Onderdonk AB, Rosner B, Cisneros RL, Kasper DL. 1993. Structural features of polysaccharides that induce intra-abdominal abscesses. Science 262(5132):416-19
128. van Bueren AL, Saraf A, Martens EC, Dijkhuizen L. 2015. Differential metabolism of exopolysaccharides from probiotic lactobacilli by the human gut symbiont Bacteroides thetaiotaomicron. Appl. Environ. Microbiol. 81(12):3973-83
129. Van der Sluis M, De Koning BAE, De Bruijn ACJM, Velcich A, Meijerink JPP, et al. 2006. Muc2-deficient mice spontaneously develop colitis, indicating that MUC2 is critical for colonic protection. Gastroenterology 131(1):117-29
130. vanHijum SAFT,Kralj S, Ozimek LK,Dijkhuizen L, van Geel-Schutten IGH. 2006. Structure-function relationships of glucansucrase and fructansucrase enzymes from lactic acid bacteria. Microbiol. Mol. Biol. Rev. 70(1):157-76
131. Walter J, Schwab C, Loach DM, Gänzle MG, Tannock GW. 2008. Glucosyltransferase A (GtfA) and inulosucrase (Inu) of Lactobacillus reuteri TMW1.106 contribute to cell aggregation, in vitro biofilm formation, and colonization of the mouse gastrointestinal tract. Microbiology 154(1):72-80
132. Wang Y, Gänzle MG, Schwab C. 2010. Exopolysaccharide synthesized by Lactobacillus reuteri decreases the ability of enterotoxigenic Escherichia coli to bind to porcine erythrocytes. Appl. Environ. Microbiol. 76(14):4863-66
133. Whitfield C. 2006. Biosynthesis and assembly of capsular polysaccharides in Escherichia coli. Annu. Rev. Biochem. 75:39-68
134. Whitfield C, Lam M. 1986. Characterisation of coliphage K30, a bacteriophage specific for Escherichia coli capsular serotype K30. FEMS Microbiol. Lett. 37(3):351-55
135. Xu J, Bjursell MK, Himrod J, Deng S, Carmichael LK, et al. 2003. A genomic view of the human-Bacteroides thetaiotaomicron symbiosis. Science 299(5615):2074-76
136. Yother J. 2011. Capsules of Streptococcus pneumoniae and other bacteria: paradigms for polysaccharide biosynthesis and regulation. Annu. Rev. Microbiol. 65:563-81
137. Ze X, Ben David Y, Laverde-Gomez JA, Dassa B, Sheridan PO, et al. 2015. Unique organization of extracellular amylases into amylosomes in the resistant starch-utilizing human colonic Firmicutes bacterium Ruminococcus bromii. mBio 6(5):e01058-15
138. Ze X, Duncan SH, Louis P, Flint HJ. 2012. Ruminococcus bromii is a keystone species for the degradation of resistant starch in the human colon. ISME J. 6(8):1535-43